Find the Perfect Plan for Your Investment Journey
E
Latest price
52 Week Range
€13.80 - €26.50
Next Earnings Date
Jul 29 2025 (Estimate)
Next Earnings Date
Jul 29 2025 (Est.)
Latest price
Market Cap | €245.57M |
EV | €252.38M |
Shares Outstanding | 10.04M |
Beta | 0.40 |
Analyst Rating | BUY |
Analyst Target Price | €30.00 |
P/E 2024E | 27.78x |
P/Revenue 2024E | 1.78x |
Revenue | -11.70% |
EPS | -52.80% |
Operating Cash Flow | -21.30% |
Free Cash Flow | -20.60% |
Revenue | 8.20% |
EPS | 31.60% |
Operating Cash Flow | 1.20% |
Free Cash Flow | -0.90% |
Gross Margin 2024E | 47.10% |
Net Profit Margin 2024E | 6.52% |
ROE 2024E | 9.40% |
ROCE 2023 | 2.78% |
DPS 2024E | - |
Payout Ratio 2024E | - |
Div. Yield 2024E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
E
Eurobio Scientific Société anonyme
ALERS
Sector
Healthcare
Industry
Medical - Devices
CEO
Fortier, Denis
Employees
329
Website
www.eurobio-scientific.comIPO Date
2005-11-18
Headquarters
7 avenue de Scandinavie, ZA de Courtaboeuf, Les Ulis, Ile-de-France, 91940, France
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved